AZD0780
AZD0780 (EX-A6975) is an oral small molecule PCSK9 inhibitor being developed by AstraZeneca as a first-in-class treatment for patients with dyslipidemia that is uncontrolled with statins alone.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
414.41
Molecular Formula
C20H20F2N6O2
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
2455427-91-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
21607124 3 x 1.0μg DNA
GLIS2 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Ask
View Details 